Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Polarization-coupled ferroelectric unipolar junction memory and energy storage device
SIC semiconductor device and method for manufacturing the same
System and method for a driver circuit with a referenced control signal
Gathering user feedback in web applications
Multi-band dipole antenna
Virtual appliance update method
Stabilized redispersible polymer powder compositions
  Randomly Featured Patents
Method and system for providing principal protection exposure to equity markets
Method and system for selecting a healthcare provider with minimal office wait times
Liquid crystal display
System and method for communicating game information between a portable gaming device and a game controller
Microelectromechanical resonators with thermally-actuated frequency tuning beams
Frozen confection
Single stage sensing apparatus for a content addressable memory
Personal restraint device
Color-change materials
Oxime ethers of Michler's hydrol, method of producing same and pressure-sensitive recording systems containing such compounds